Get started
MODERNAMODERNAMODERNA

MODERNA

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

4MRNA trade ideas

$MRNA - Possible ReversalNASDAQ:MRNA Is basing inside descending broadening wedge and starting to break out. Both RSI and MACD is displaying bullish divergence. $126 - $127 is POC resistance and breaking above that area will be bullish. Notice that the stock is in Stage 1 bottoming process. So it has a lot of room to run. I will be building a position in the coming week. Targets - $160, $180, $210 Risk - $100, $60 If you like this tweet, don't forget to follow, like and retweet.
NASDAQ:MRNALong
by PaperBozz
2
Downtrend Continuation for $MRNA :-)The hype of elixir ability of mRNA vaccines by Moderna has reached a peak in Aug 2021 Price reached as high as 500 dollar. But it turns negative after that. after a massive plunge, price has been consolidating between 118 - 208 for more than 1.5 years, it looks like price has been hovering around 118 to go lower. If the downtrend continues after the consolidation, chances are high that in the next 1.5 years or so, price will fall back between 50 - 80 I am prone towards more downside, although i could be wrong This is just my own research and should never be construed as buy or sell call
NASDAQ:MRNAShort
by jangseohee
2
Profits Over Patients: The Morally Complex Realm of Big PharmaThis strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price manipulation is a notorious strategy where companies arbitrarily hike drug prices, often without any significant improvements in their efficacy. "Big Pharma" has faced backlash for allegedly contributing to the opioid crisis . By aggressively marketing highly addictive pain medications , they may have exacerbated a public health catastrophe, leading to thousands of deaths annually. Such practices illuminate the immoral landscape of the pharmaceutical industry. While these firms play a vital role in global healthcare, their business tactics often prioritize profits over patients, demanding a closer scrutiny of this sector's ethics. 1. Johnson & Johnson (JNJ): Around $440 billion 2. Pfizer Inc. (PFE): Around $240 billion 3. Moderna Inc. (MRNA): Around $110 billion 4. Merck & Co., Inc. (MRK): Around $200 billion TOTAL = 1 Trillion
NASDAQ:MRNA
by MichaelBsul
MRNA ? Buy Weakness MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into earnings tomorrow. MRNA needs to show something good otherwise it will break through the demand zone and keep going down. This is a risky earnings play betting that something will show up on the report to buoy up the company and its stock. I will risk 0.01% of the trading account on a call option with DTE 5/19/23 looking for a minor surge and so a good quick profit. ( see also the link below)
NASDAQ:MRNALong
by AwesomeAvani
Moderna Very Bearish (Pt 2)Part 1: The136.50 target was hit and Moderna is now resting at a critical neckline area which bulls have defended for quite some time. I expect a small bounce here but ultimately, a break of this level and a spill much lower. View of the weekly chart below: This is a head and shoulders within a head & shoulders playing out. It would be invalidated if MRNA can retake the 20 weekly moving average (165.32) and flip it to support. Bearish price target: 73USD!
NASDAQ:MRNAShort
by EquityCast
Moderna to 136.50I will be looking for a short tomorrow on any bounce. Bearish marubozo daily candle with a rejection of the 200DMA, cutting through the 50DMA(green) then 20DMA(yellow) like butter and on monster volume. Not good! High probability of downside continuation tomorrow & the 20 + 50 DMAs will now flip from support to resistance. Downside price target: Major area of support/confluence at 136.50. While this is in my opinion the most probable scenario, let's scenario cast a few others: Potential bullish scenarios (neither which is likely to me!) 1.) A gap-up tomorrow then tight trading range day creating a bullish harami. 2.) Further initial continuation tomorrow followed by bulls pushing back hard creating either a hammer or pinbar daily candle signaling a potential bounce to the 2 major moving average resistances.
NASDAQ:MRNAShort
by EquityCast